MYD88L265P通过与DOCK8的相互作用,在大型B细胞淋巴瘤中增加了近端B细胞受体信号传递
Elisa Mandato1, Qingsheng Yan1, Jing Ouyang1,2
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Blood
|July 19, 2023
概括
在MYD88和CD79B的突变增强B细胞受体信号在扩散性大B细胞淋巴瘤 (DLBCL). 这种涉及DOCK8的交叉解释了DLBCL对布鲁顿氨酸激酶 (BTK) 抑制剂的敏感性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种具有明显分子亚型的异质癌症.
- 集群5 (C5) /MCDDLBCLs,以MYD88和CD79B改变为特征,预后较差.
- 收费类受体 (TLR) 和B细胞受体 (BCR) 途径在B细胞中协同作用,影响免疫反应和NF-κB激活.
研究的目的:
- 调查突变MYD88在DLBCL内的近端BCR信号传递中的作用.
- 阐明C5/MCDDLBCLs对布鲁顿氨酸激酶 (BTK) 抑制的敏感性背后的机制.
主要方法:
- 使用工程设计的DLBCL细胞系模型.
- 分析了信号通路,包括腺氨酸激酶 (SYK),BTK,PYK2和DOCK8.8等.
- 研究了蛋白质同位素化和DOCK8枯竭的影响.
主要成果:
- 同时发生的MYD88L265P和CD79B变异显著放大了近位BCR信号传递 (SYK,BTK) 和PYK2-依赖的DOCK8酸化.
- 在MYD88L265PDLBCL中,DOCK8与MYD88和LYN激酶的同位化增加表明DOCK8参与了通路交叉.
- DOCK8 枯竭减少了DLBCL 扩散和活力,并提高了BTK 抑制剂的有效性.
结论:
- MYD88L265P/DOCK8增强的近接BCR信号是驱动C5/MCD DLBCL对BTK封锁敏感性的关键机制.
- 针对这种途径可能为特定的DLBCL亚型提供治疗策略.
相关概念视频
Assembly of Signaling Complexes
5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
T Cell Activation and Clonal Selection
815
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
815
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


